SPIN technology uses a two-step screening method to identify single plasma cells and clone high-affinity antigen-specific antibody genes using both surface and cytoplasmic markers for plasma cell identification for antibody development.
SPIN technology uses a two-step screening method to identify single plasma cells and clone high-affinity antigen-specific antibody genes. It is the first method to use both surface markers and cytoplasmic markers for plasma cell identification for antibody development.